Roche
Swiss multinational healthcare company
Follow Roche on Notably News to receive short updates to your email — rarely!
| 2024 | Roche projected revenue of 62.39 billion CHF and net income of 9.19 billion CHF, indicating continued financial monitoring. |
| November 2024 | Roche acquired Poseida Therapeutics for US $1.0 billion. |
| March 2024 | Roche sold Genentech's site in Vacaville, California to Lonza for $1.2 billion. |
| 2023 | The company's revenue slightly decreased to 60.44 billion CHF, with net income reducing to 12.36 billion CHF. |
| 2023 | Roche was ranked 76th in the Forbes Global 2000 list, maintaining its position as the fifth-largest pharmaceutical company in the world by revenue and the leading global provider of cancer treatments. |
| 2022 | Roche continued its strong financial performance with revenue reaching 66.43 billion CHF and net income of 13.53 billion CHF. |
| 2021 | The company rebounded with revenue of 62.801 billion CHF and net income of 14.935 billion CHF. |
| 2020 | Roche reported annual revenues of 58.32 billion Swiss francs for the fiscal year, and continued its streak of increasing dividends for the 34th consecutive year. |
| March 2020 | Roche Diagnostics received FDA approval for a high-volume Sars-CoV-2 diagnostic test capable of analyzing 1,400-8,800 samples within 24 hours. |
| 2019 | The company reached a revenue milestone of 63.751 billion CHF, with net income substantially increasing to 14.108 billion CHF. |
| 2018 | Roche saw significant revenue growth to 56.846 billion CHF and a notable increase in net income to 10.865 billion CHF. |
| 2017 | The company's revenue reached 53.299 billion CHF, with net income slightly decreasing to 8.633 billion CHF. |
| 2016 | Roche experienced revenue growth to 50.576 billion CHF and net income increase to 9.576 billion CHF. |
| 2015 | The company continued its financial trajectory with revenue of 48.145 billion CHF and net income of 8.863 billion CHF. |
| 2014 | Roche increased its annual revenue to 47.462 billion CHF and saw a decrease in net income to 9.332 billion CHF. |
| 2013 | Roche reported annual revenue of 46.780 billion CHF, demonstrating the company's significant financial performance. |
| June 26 2012 | Announced closure of the Nutley/Clifton campus, completed in 2013. |
This contents of the box above is based on material from the Wikipedia article Roche, which is released under the Creative Commons Attribution-ShareAlike 4.0 International License.